{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T11:25:41Z","timestamp":1794914741089,"version":"4.9.1"},"reference-count":56,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVES<\/jats:title>\n                  <jats:p>Describe clinical characteristics of adolescents hospitalized with e-cigarette or vaping product use-associated lung injury (EVALI) and to investigate association between EVALI and coagulopathy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>We conducted a retrospective cohort study of adolescents admitted to the general inpatient or ICUs at 2 major tertiary children\u2019s hospitals from January 2019 to June 2021. We included analysis of demographics, clinical findings, laboratory and imaging results, and outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Forty-four hospitalizations met diagnostic criteria for inclusion per Centers for Disease Control and Prevention guidelines, with 55% of patients admitted after April 2020. Compared with adults, pediatric patients were less likely to present with pulmonary symptoms. Significant laboratory work included elevated white blood cell count of 14.3 k\/uL (confidence interval [CI], 13.7\u201315.0) with neutrophilic predominance, C-reactive protein of 25.2 mg\/dL (CI, 22.1\u201328.2), and erythrocyte sedimentation rate of 66.7 mm\/hour (CI, 26.9\u201376.4). Chest radiographs were poor predictors of disease in 53% of our patients but computed tomography was 100% sensitive. Significant coagulation abnormalities included prothrombin time of 17.7 seconds (CI, 16.4\u201319.1) and international normalized ratio of 1.54 (CI, 1.43\u20131.66). Coagulation studies improved with vitamin K and steroid administration. Nine of 16 patients (56%) had abnormal diffusing capacity of the lung for carbon monoxide divided by alveolar volume &amp;lt;80% predicted, suggesting evidence of pulmonary vascular disease, or &amp;gt;100%, suggesting pulmonary hemorrhage.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>EVALI continues to be an important differential diagnosis in the adolescent population. EVALI is likely a result of systemic inflammation with consequences beyond the pulmonary system. The novel report of coagulopathy among adolescents with EVALI in this cohort reveals an opportunity to detect coagulopathy and initiate early therapy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/hpeds.2021-006059","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T08:10:55Z","timestamp":1643616655000},"page":"229-240","source":"Crossref","is-referenced-by-count":6,"title":["Clinical Findings in Adolescents Hospitalized With EVALI; Novel Report on Coagulopathy"],"prefix":"10.1542","volume":"12","author":[{"given":"Gift","family":"Kopsombut","sequence":"first","affiliation":[{"name":"Departments of Hospital Medicine"},{"name":"Clinical Informatics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini","family":"Ajjegowda","sequence":"additional","affiliation":[{"name":"Graduate Medical Education"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floyd","family":"Livingston","sequence":"additional","affiliation":[{"name":"Pulmonology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Epelman","sequence":"additional","affiliation":[{"name":"Radiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Brown","sequence":"additional","affiliation":[{"name":"Pulmonology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Werk","sequence":"additional","affiliation":[{"name":"General Academic Pediatrics, Nemours Children\u2019s Hospital, Orlando, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Brogan","sequence":"additional","affiliation":[{"name":"Departments of Hospital Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2022,1,31]]},"reference":[{"key":"2022020117490123600_b1","unstructured":"U.S. Food & Drug Administration. Vaporizers, e-cigarettes, and other electronic nicotine delivery systems (ENDS). Available at: https:\/\/www.fda.gov\/tobacco-products\/products-ingredients- components\/vaporizers-e-cigarettes-and- other-electronic-nicotine-delivery-systems- ends. 2020. Accessed January 2021"},{"issue":"36","key":"2022020117490123600_b2","doi-asserted-by":"crossref","first-page":"787","DOI":"10.15585\/mmwr.mm6836e2","article-title":"Severe pulmonary disease associated with electronic-cigarette\u2013product use \u2013 interim guidance","volume":"68","author":"Schier","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022020117490123600_b3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.drugalcdep.2019.04.011","article-title":"The rise of e-cigarettes, pod mod devices, and JUUL among youth: Factors influencing use, health implications, and downstream effects","volume":"201","author":"Fadus","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"2022020117490123600_b4","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/tobaccocontrol-2018-054565","article-title":"High exposure to nicotine among adolescents who use Juul and other vape pod systems (\u2018pods\u2019)","volume":"28","author":"Goniewicz","year":"2019","journal-title":"Tob Control"},{"key":"2022020117490123600_b5","doi-asserted-by":"crossref","first-page":"107512","DOI":"10.1016\/j.drugalcdep.2019.05.032","article-title":"Adolescents\u2019 awareness of the nicotine strength and e-cigarette status of JUUL e-cigarettes","volume":"204","author":"Morean","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"2022020117490123600_b6","unstructured":"Johnston\n              LD\n            , O\u2019MalleyPM, MiechRA, BachmanJG, SchulenbergJE Z. National Institute on Drug Abuse (DHHS\/PHS). Monitoring the future national survey results on drug use, 1975-2016: overview, key findings on adolescent drug use. Available at: https:\/\/eric.ed.gov\/?id=ED578534. Accessed January 5, 2022"},{"key":"2022020117490123600_b7","unstructured":"Centers for Disease Control and Prevention for Healthcare Providers. Available at: https:\/\/www.cdc.gov\/tobacco\/basic_information\/e-cigarettes\/severe-lung-disease\/healthcare- providers\/index.html. 2020. Accessed January 30, 2021"},{"issue":"41","key":"2022020117490123600_b8","doi-asserted-by":"crossref","first-page":"919","DOI":"10.15585\/mmwr.mm6841e3","article-title":"Update: interim guidance for health care providers evaluating and caring for patients with suspected e-cigarette, or vaping, product use associated lung injury - United States, October 2019","volume":"68","author":"Siegel","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"2022020117490123600_b9","doi-asserted-by":"crossref","first-page":"e20193408","DOI":"10.1542\/peds.2019-3408","article-title":"E-cigarette or vaping product use\u2013associated lung injury (EVALI) without respiratory symptoms","volume":"145","author":"Matta","year":"2020","journal-title":"Pediatrics"},{"issue":"1","key":"2022020117490123600_b10","doi-asserted-by":"crossref","first-page":"e20194104","DOI":"10.1542\/peds.2019-4104","article-title":"Clinical features of e-cigarette, or vaping, product use-associated lung injury in teenagers","volume":"146","author":"Rao","year":"2020","journal-title":"Pediatrics"},{"issue":"5","key":"2022020117490123600_b11","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2214\/AJR.20.22836","article-title":"Radiologic and pathologic correlation in EVALI","volume":"215","author":"Panse","year":"2020","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"2022020117490123600_b12","doi-asserted-by":"crossref","first-page":"498","DOI":"10.2214\/AJR.19.22251","article-title":"Imaging findings of vaping-associated lung injury","volume":"214","author":"Henry","year":"2020","journal-title":"AJR Am J Roentgenol"},{"key":"2022020117490123600_b13","first-page":"9724530","article-title":"Diffuse alveolar hemorrhage induced by vaping","volume":"2018","author":"Agustin","year":"2018","journal-title":"Case Rep Pulmonol"},{"key":"2022020117490123600_b14","first-page":"100996","article-title":"Vaping-induced diffuse alveolar hemorrhage","volume":"29","author":"Edmonds","year":"2020","journal-title":"Respir Med Case Rep"},{"issue":"12","key":"2022020117490123600_b15","first-page":"e6519","article-title":"Diffuse alveolar hemorrhage: an uncommon manifestation of vaping-associated lung injury","volume":"11","author":"Wilhite","year":"2019","journal-title":"Cureus"},{"issue":"1","key":"2022020117490123600_b16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00408-019-00277-6","article-title":"Vaping-associated acute respiratory failure due to acute lipoid pneumonia","volume":"198","author":"Dicpinigaitis","year":"2020","journal-title":"Lung"},{"issue":"1","key":"2022020117490123600_b17","doi-asserted-by":"crossref","first-page":"2000143","DOI":"10.1183\/13993003.00143-2020","article-title":"Diffuse alveolar haemorrhage secondary to e-cigarette \u201cvaping\u201d associated lung injury (EVALI) in a young European consumer","volume":"56","author":"Villeneuve","year":"2020","journal-title":"Eur Respir J"},{"key":"2022020117490123600_b18","first-page":"6138083","article-title":"A case of vaping TCH oil leading to vaping associated pulmonary injury: our approach to its diagnosis, management, and recommendations","volume":"2020","author":"Singh","year":"2020","journal-title":"Case Rep Pulmonol"},{"key":"2022020117490123600_b19","first-page":"A1845","article-title":"Vaping-induced pulmonary hemorrhage","volume":"201","author":"Harrington","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2022020117490123600_b20","first-page":"101038","article-title":"Vaping-associated diffuse alveolar hemorrhage - a case report","volume":"30","author":"Shehata","year":"2020","journal-title":"Respir Med Case Rep"},{"issue":"4","key":"2022020117490123600_b21","first-page":"11555","article-title":"Vaping related acute parenchymal injury, a systematic review","volume":"58","author":"Jones","year":"2020","journal-title":"Chest"},{"issue":"36","key":"2022020117490123600_b22","doi-asserted-by":"crossref","first-page":"787","DOI":"10.15585\/mmwr.mm6836e2","article-title":"Severe pulmonary disease associated with electronic-cigarette\u2013product use \u2013 interim guidance","volume":"68","author":"Schier","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"2022020117490123600_b23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2141.2009.07600.x","article-title":"Guidelines for the diagnosis and management of disseminated intravascular coagulation","volume":"145","author":"Levi","year":"2009","journal-title":"Br J Haematol"},{"issue":"5","key":"2022020117490123600_b24","first-page":"359","article-title":"A stepwise approach to the interpretation of pulmonary function tests","volume":"89","author":"Johnson","year":"2014","journal-title":"Am Fam Physician"},{"issue":"10","key":"2022020117490123600_b25","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1056\/NEJMoa1911614","article-title":"Pulmonary illness related to e-cigarette use in Illinois and Wisconsin - final report","volume":"382","author":"Layden","year":"2020","journal-title":"N Engl J Med"},{"issue":"10214","key":"2022020117490123600_b26","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(19)32679-0","article-title":"Clinical presentation, treatment, and short-term outcomes of lung injury associated with e-cigarettes or vaping: a prospective observational cohort study","volume":"394","author":"Blagev","year":"2019","journal-title":"Lancet"},{"issue":"12","key":"2022020117490123600_b27","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S2213-2600(19)30415-1","article-title":"E-cigarette, or vaping, product use associated lung injury (EVALI): case series and diagnostic approach","volume":"7","author":"Kalininskiy","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"1","key":"2022020117490123600_b28","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ppul.25086","article-title":"Characterizing e-cigarette vaping-associated lung injury in the pediatric intensive care unit","volume":"56","author":"Reddy","year":"2020","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"2022020117490123600_b29","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.chest.2020.06.029","article-title":"Diagnosing EVALI in the Time of COVID-19","volume":"158","author":"Callahan","year":"2020","journal-title":"Chest"},{"key":"2022020117490123600_b30","unstructured":"Centers for Disease Control. COVID-19 treatment guidelines. Corticosteroids. Available at: https:\/\/www.covid19 treatmentguidelines.nih.gov\/therapies\/immunomodulators\/corticosteroids\/. 2020. Accessed July 2021"},{"issue":"11","key":"2022020117490123600_b31","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1111\/jth.15073","article-title":"Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19-related illness","volume":"18","author":"Goldenberg","year":"2020","journal-title":"J Thromb Haemost"},{"key":"2022020117490123600_b32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.envpol.2014.10.013","article-title":"Aerosol deposition doses in the human respiratory tree of electronic cigarette smokers","volume":"196","author":"Manigrasso","year":"2015","journal-title":"Environ Pollut"},{"issue":"2","key":"2022020117490123600_b33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12011-018-1423-x","article-title":"Health effects of trace metals in electronic cigarette aerosols: a systematic review","volume":"188","author":"Gaur","year":"2019","journal-title":"Biol Trace Elem Res"},{"issue":"12","key":"2022020117490123600_b34","doi-asserted-by":"crossref","first-page":"6349","DOI":"10.1073\/pnas.1920925117","article-title":"Potential for release of pulmonary toxic ketene from vaping pyrolysis of vitamin E acetate","volume":"117","author":"Wu","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2022020117490123600_b35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/toxics8030046","article-title":"Pulmonary toxicity and inflammatory response of e-cigarette vape cartridges containing medium-chain triglycerides oil and vitamin E acetate: implications in the pathogenesis of EVALI","volume":"8","author":"Muthumalage","year":"2020","journal-title":"Toxics"},{"issue":"2","key":"2022020117490123600_b36","doi-asserted-by":"crossref","first-page":"e0116732","DOI":"10.1371\/journal.pone.0116732","article-title":"Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung","volume":"10","author":"Lerner","year":"2015","journal-title":"PLoS One"},{"key":"2022020117490123600_b37","doi-asserted-by":"crossref","first-page":"102982","DOI":"10.1016\/j.ebiom.2020.102982","article-title":"Lipid laden macrophages and electronic cigarettes in healthy adults","volume":"60","author":"Shields","year":"2020","journal-title":"EBioMedicine"},{"issue":"2","key":"2022020117490123600_b38","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1158\/1055-9965.EPI-19-1245","article-title":"Biomarkers of exposure and effect in the lungs of smokers, nonsmokers, and electronic cigarette users","volume":"29","author":"Song","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"2022020117490123600_b39","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.amjmed.2019.11.007","article-title":"Coagulopathy and inflammatory dysregulation with e-cigarette use","volume":"133","author":"Khanijo","year":"2020","journal-title":"Am J Med"},{"issue":"2","key":"2022020117490123600_b40","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/cc6866","article-title":"The inflammation-coagulation axis as an important intermediate pathway in acute lung injury","volume":"12","author":"Levi","year":"2008","journal-title":"Crit Care"},{"issue":"1","key":"2022020117490123600_b41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/ajcn\/80.1.143","article-title":"Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status","volume":"80","author":"Booth","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"2022020117490123600_b42","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1177\/1074248420941681","article-title":"The JUUL E-Cigarette Elevates the Risk of Thrombosis and Potentiates Platelet Activation","volume":"25","author":"Ramirez","year":"2020","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"9","key":"2022020117490123600_b43","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.amjcard.2018.07.029","article-title":"Impact of tobacco versus electronic cigarette smoking on platelet function","volume":"122","author":"Nocella","year":"2018","journal-title":"Am J Cardiol"},{"issue":"15","key":"2022020117490123600_b44","doi-asserted-by":"crossref","first-page":"e009264","DOI":"10.1161\/JAHA.118.009264","article-title":"Short-term e-cigarette exposure increases the risk of thrombogenesis and enhances platelet function in mice","volume":"7","author":"Qasim","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2022020117490123600_b45","doi-asserted-by":"crossref","first-page":"e929915-1","DOI":"10.12659\/AJCR.929915","article-title":"A 20-year-old man with e-cigarette or vaping product use-associated lung injury (EVALI) and thrombotic coagulopathy","volume":"22","author":"Harada","year":"2021","journal-title":"Am J Case Rep"},{"issue":"4","key":"2022020117490123600_b46","doi-asserted-by":"crossref","first-page":"A2377","DOI":"10.1016\/j.chest.2020.08.2018","article-title":"Short-term pulmonary function test characteristics in patients diagnosed with e-cigarette or vaping associated lung injury","volume":"158","author":"Anderson","year":"2020","journal-title":"Chest"},{"key":"2022020117490123600_b47","first-page":"A7684","article-title":"Pulmonary function testing in vaping associated lung injury","volume":"201","author":"Tsirilakis","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2022020117490123600_b48","first-page":"e7002","article-title":"Long-term impact of e-cigarette and vaping product use-associated lung injury on diffusing capacity for carbon monoxide values: case series","volume":"12","author":"Ahmad","year":"2020","journal-title":"Cureus"},{"issue":"7","key":"2022020117490123600_b49","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/ppul.24787","article-title":"Impaired lung function following e-cigarette or vaping product use associated lung injury in the first cohort of hospitalized adolescents","volume":"55","author":"Carroll","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"2022020117490123600_b50","unstructured":"Lee\n              J\n            \n          . Merck Manual. Diffuse alveolar hemorrhage. Available at: https:\/\/www.merckmanuals.com\/professional\/pulmonary-disorders\/diffuse-alveolar -hemorrhage-and-pulmonary-renal- syndrome\/diffuse-alveolar-hemorrhage. Accessed January 15, 2021"},{"issue":"2","key":"2022020117490123600_b51","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1148\/radiol.2020192778","article-title":"Pediatric chest radiographic and CT findings of electronic cigarette or vaping product use-associated lung injury (EVALI)","volume":"295","author":"Artunduaga","year":"2020","journal-title":"Radiology"},{"issue":"3","key":"2022020117490123600_b52","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2214\/AJR.20.23267","article-title":"Pediatric SARS, H1N1, MERS, EVALI, and Now Coronavirus Disease (COVID-19) pneumonia: what radiologists need to know","volume":"215","author":"Foust","year":"2020","journal-title":"AJR Am J Roentgenol"},{"issue":"18","key":"2022020117490123600_b53","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1056\/NEJMc1913069","article-title":"Pathology of vaping-associated lung injury","volume":"381","author":"Butt","year":"2019","journal-title":"N Engl J Med"},{"issue":"6","key":"2022020117490123600_b54","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.hrtlng.2020.06.008","article-title":"COVID-19 pneumonia versus EVALI, distinguishing the overlapping CT features in the COVID-19 era","volume":"49","author":"Ansari-Gilani","year":"2020","journal-title":"Heart Lung"},{"issue":"7","key":"2022020117490123600_b55","doi-asserted-by":"crossref","first-page":"e200756","DOI":"10.1001\/jamapediatrics.2020.0756","article-title":"Demographics, substance use behaviors, and clinical characteristics of adolescents with e-cigarette, or vaping, product use-associated lung injury (EVALI) in the United States in 2019","volume":"174","author":"Adkins","year":"2020","journal-title":"JAMA Pediatr"},{"key":"2022020117490123600_b56","unstructured":"Centers for Disease Control and Prevention. Anxiety and depression in children: get the facts. Available at: https:\/\/www.cdc.gov\/childrensmentalhealth\/features\/anxiety-depression-children.html. 2020. Accessed January 18, 2021"}],"container-title":["Hospital Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/12\/2\/229\/1255446\/hpeds.2021-006059.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/12\/2\/229\/1255446\/hpeds.2021-006059.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T17:55:49Z","timestamp":1643738149000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article\/12\/2\/229\/184521\/Clinical-Findings-in-Adolescents-Hospitalized-With"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":56,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,1,31]]},"published-print":{"date-parts":[[2022,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/hpeds.2021-006059","relation":{},"ISSN":["2154-1663","2154-1671"],"issn-type":[{"value":"2154-1663","type":"print"},{"value":"2154-1671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,31]]}}}